Science Current Events | Science News | Brightsurf.com
 

Nursing home residents at heightened risk of falling in the days following

July 18, 2011
Increased surveillance over 48-hour period may decrease falls

BOSTON-Nursing home residents taking certain antidepressant medications are at an increased risk of falling in the days following the start of a new prescription or a dose increase of their current drug, according to a new study by the Institute for Aging Research of Hebrew SeniorLife, an affiliate of Harvard Medical School.

Published online in the Journal of Gerontology: Medical Sciences, the study found that nursing home residents have a fivefold increased risk of falling within two days of a new prescription for or an increased dose of a non-SSRI (selective serotonin reuptake inhibitor) antidepressant such as bupropion or venlafaxine. The findings suggest that nursing home staff should closely monitor these residents following a prescription change to prevent potential falls.

"Our results," says lead author Sarah D. Berry, M.D., M.P.H., a scientist at the Institute for Aging Research, "identify the days following a new prescription or increased dose of a non-SSRI antidepressant as a window of time associated with a particularly high risk of falling among nursing home residents."

The risk of falls, she says, may be due to acute cognitive or motor effects that have not yet been fully investigated. Certain non-SSRIs, such as trazodone, can cause postural hypotension, a dramatic decrease in blood pressure upon standing that may contribute to falls. Other non-SSRIs, like venlafaxine, can cause sedation and coordination problems that may lead to falls.

According to some estimates, more than one-third of the country's nearly 1.6 million nursing home residents take some type of antidepressant medication. Several previous studies have implicated antidepressants, including both SSRIs, such as paroxetine and sertraline, and non-SSRIs, as a risk factor for falls, especially among older adults; however, it is unclear if the risk accrues during the duration of use or if there are acute risks associated with the initiation or change in dose of a prescription.

Both tricyclic antidepressants and SSRIs, the most commonly prescribed antidepressant medications, have been associated with up to a sixfold increased risk of falls among nursing home residents in other studies. Newer drugs, including serotonin-norepinephrine reuptake inhibitors, may also be associated with falls risk. Regardless, says Dr. Berry, "these drugs are effective at treating the symptoms of depression, and many clinicians are reluctant to withhold their use based solely on a risk for falls."

Although many studies have examined chronic antidepressant use as a risk factor for falls, few have considered the short-term effects of a change in antidepressant prescription. Dr. Berry's study, called a case-crossover study, examined 1,181 residents of a Boston-area nursing home who fell, comparing the frequency of antidepressant changes during a "hazard" period (1-7 days before a fall) with the frequency of antidepressant changes during a control period (8-14 days before a fall). Information on falls was collected using the facility's federally-mandated computerized incident reports. The risk of falls was greatest within a two-day period of a change in a non-SSRI prescription (either new or existing), while no association was found between SSRIs and falls. The risk of falls diminished each day following the prescription change.

In light of her findings, says Dr. Berry, an instructor in medicine at Harvard Medical School, "nursing home staff should keep a watchful eye on residents in the days following a non-SSRI antidepressant change to prevent falls and clinicians should avoid making changes on weekends or during times when unfamiliar staff is present."

###

The study was funded by a grant from the National Institute on Aging, the Hartford Geriatrics Health Outcomes Research Scholars Awards Program, and the Men's Associates of Hebrew SeniorLife.

Scientists at the Institute for Aging Research seek to transform the human experience of aging by conducting research that will ensure a life of health, dignity and productivity into advanced age. The Institute carries out rigorous studies that discover the mechanisms of age-related disease and disability; lead to the prevention, treatment and cure of disease; advance the standard of care for older people; and inform public decision-making.

Founded in 1903, Hebrew SeniorLife, an affiliate of Harvard Medical School, is a nonprofit, nonsectarian organization devoted to innovative research, health care, education and housing that improves the lives of seniors. For more information, please visit www.hebrewseniorlife.org.

Hebrew SeniorLife Institute for Aging Research


Related Antidepressant Current Events and Antidepressant News Articles


Stress-related inflammation may increase risk for depression
Preexisting differences in the sensitivity of a key part of each individual's immune system to stress confer a greater risk of developing stress-related depression or anxiety, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published October 20 in the Proceedings of the National Academy of Sciences (PNAS).

Analgesics and anti-inflammatory drugs may have an impact on depression
Ordinary over the counter painkillers and anti-inflammatory drugs purchased from pharmacies may also be effective in the treatment of people suffering of depression.

I have anxiety, why is my doctor prescribing an antipsychotic?
What's in a name? Doctors have found that the name of the drug you are prescribed significantly influences how the patient sees the treatment.

New research shows fish intake associated with boost to antidepressant response
Up to half of patients who suffer from depression (Major Depressive Disorder, or MDD) do not respond to treatment with SSRIs (Selective Serotonin Reuptake Inhibitors).

Rapid agent restores pleasure-seeking ahead of other antidepressant action
A drug being studied as a fast-acting mood-lifter restored pleasure-seeking behavior independent of - and ahead of - its other antidepressant effects, in a National Institutes of Health trial.

Reports new study in Biological Psychiatry
Patients with increased inflammation, including those receiving cytokines for medical treatment, have a greatly increased risk of depression. For example, a 6-month treatment course of interferon-alpha therapy for chronic hepatitis C virus infection causes depression in approximately 30% of patients.

Selectively Rewiring the Brain's Circuitry to Treat Depression
On Star Trek, it is easy to take for granted the incredible ability of futuristic doctors to wave small devices over the heads of both humans and aliens, diagnose their problems through evaluating changes in brain activity or chemistry, and then treat behavior problems by selectively stimulating relevant brain circuits.

Brief depression questionnaires could lead to unnecessary antidepressant prescriptions
Short questionnaires used to identify patients at risk for depression are linked with antidepressant medications being prescribed when they may not be needed, according to new research from UC Davis Health System published in the September-October issue of the Journal of the American Board of Family Medicine.

Scientists discover 'dimmer switch' for mood disorders
Researchers at University of California, San Diego School of Medicine have identified a control mechanism for an area of the brain that processes sensory and emotive information that humans experience as "disappointment."

Single dose of antidepressant changes the brain
A single dose of antidepressant is enough to produce dramatic changes in the functional architecture of the human brain. Brain scans taken of people before and after an acute dose of a commonly prescribed SSRI (serotonin reuptake inhibitor) reveal changes in connectivity within three hours.
More Antidepressant Current Events and Antidepressant News Articles

The Anti-Depressant Fact Book: What Your Doctor Won't Tell You About Prozac, Zoloft, Paxil, Celexa, and Luvox

The Anti-Depressant Fact Book: What Your Doctor Won't Tell You About Prozac, Zoloft, Paxil, Celexa, and Luvox
by Peter R. Breggin (Author)


Known as "the Ralph Nader of psychiatry," Dr. Peter Breggin has been the medical expert in countless court cases involving the use or misuse of psychoactive medications. This unusual position has given him unprecedented access to private pharmaceutical research and correspondence files, information from which informs this straight-talking guide to the most prescribed and controversial category of American drugs: antidepressants. From how these drugs work in the brain to how they treat (or don't treat) depression and obsessive-compulsive, panic, and other disorders; from the documented side and withdrawal effects to what every parent needs to know about antidepressants and teenagers, The Anti-Depressant Fact Book is up-to-the minute and easy-to-access. Hard-hitting and enlightening, every...

The Antidepressant Solution: A Step-by-Step Guide to Safely Overcoming Antidepressant Withdrawal, Dependence, and "Addiction"

The Antidepressant Solution: A Step-by-Step Guide to Safely Overcoming Antidepressant Withdrawal, Dependence, and "Addiction"
by M.D. Joseph Glenmullen M.D. (Author)


With the FDA's warning that antidepressants may cause agitation, anxiety, hostility, and even violent or suicidal tendencies, these medications are at the forefront of national legal news. Harvard physician Joseph Glenmullen has led the charge to warn the public that antidepressants are overprescribed, underregulated, and, especially, misunderstood in their side and withdrawal effects. Now he offers a solution!

More than twenty million Americans -- including over one million teens and children -- take one of today's popular antidepressants, such as Paxil, Zoloft, or Effexor. Dr. Glenmullen recognizes the many benefits of antidepressants and prescribes them to his patients, but he is also committed to warning the public of the dangers associated with overprescription. Dr....

Taking Antidepressants: Your Comprehensive Guide to Starting, Staying On, and Safely Quitting

Taking Antidepressants: Your Comprehensive Guide to Starting, Staying On, and Safely Quitting
by Michael Banov (Author)


Walks readers with depression through a personalized process to help them make the right choice about starting, staying on, and stopping antidepressants.

Medications for Anxiety & Depression - A guide to choosing the antidepressant or antianxiety medication that's right for you

Medications for Anxiety & Depression - A guide to choosing the antidepressant or antianxiety medication that's right for you


Are you confused about which antidepressant is right for you? Would you like to learn all the important information on all of the antidepressants currently available?All medications are not equal. Just like a carpenter, you need the right tool for the job. Don't just rely on your doctor - take a proactive role in managing your recovery!Unfortunately, doctors tend to be incredibly busy. Sometimes they just don't have the time to get all the details they need to choose the right medication for you. This means that very often, you will just be prescribed the drug that your doctor has the most experience in. This may or may not be the right tool for the job.Depression and anxiety are incredibly varied conditions. Some people are "anxious depressed" whereas others can be more "low...

The Latest Antidepressants: "Must Know" Information About  Vilazodone (Viibryd®),  Levomilnacipran (Fetzima®), Vortioxetine (Brintellix®), and Lurasidone (Latuda®). (Series: Simple and Practical)

The Latest Antidepressants: "Must Know" Information About Vilazodone (Viibryd®), Levomilnacipran (Fetzima®), Vortioxetine (Brintellix®), and Lurasidone (Latuda®). (Series: Simple and Practical)
by Simple and Practical: The Name Says It All.


If a patient comes in on one the newest antidepressants OR you need to try one of them, will you know what is clinically needed or very little about them? If a drug rep tries to “educate” you about one of the newest antidepressants, will you need that education and not know how to separate the facts from the hype? Or will you be an “up-to-date clinician” who has briefly reviewed key issues and can speak confidently about the medication?

Two problems, however. Who has time to read original papers and even complex review articles with dozens of references? Also, even if you took a week off to read the vast amount of data on these antidepressants, unless you are a researcher in this specific area and have some background in biostatistics, it is not easy to interpret the...

Dr. Shipko's Informed Consent for SSRI Antidepressants

Dr. Shipko's Informed Consent for SSRI Antidepressants


I am writing this eBook to share the key information that I discuss with patients in consultation before starting or stopping a serotonin reuptake inhibitor (SSRI) antidepressant. ‘Informed Consent’ is not intended to be a comprehensive book about these drugs, rather, it duplicates the information that I typically provide to my patients when I see them in consultation. If you are contemplating starting or stopping an SSRI antidepressant, then you will find this information helpful.

Antidepressants: The Practitioner's Guide

Antidepressants: The Practitioner's Guide
by Dr. Shlomo Brook M.D. (Author)


Depression is a common and debilitating condition, which affects approximately one in eight people. In addition, it is expected to be the second-leading cause of disability in the world by the year 2020. Depression can be treated successfully and remission is the aim and it is associated with a return of normal psycho-social function, lack of disabling symptoms and overall a better prognosis.

Thank God for Anti-Depressants!: A Journey to New Beginnings

Thank God for Anti-Depressants!: A Journey to New Beginnings
by Jane Newman (Author)


Thank God for antidepressants is about honesty and putting things in the light: the struggles, the fears, the frailty and the questions of Jane Newman’s journey to a life of fulfilment in spite of the on-going need of anti-depressants. Jane Newman understands the personal challenges of long-term medication and the fall-out on family relationships and personal identity. Thank God for antidepressants is a conversational journey about such questions as… - How did I get here? - Where does depression come from? - To take, or not to take anti-depressants? - Why do people treat me differently? - Do the meds make me a different person? - Which side-effects can I live with? - What about Psychotherapy? - Am I a second class citizen? - Where is God in all that? - What do we tell the children?...

Quitting Antidepressants the Smart Way - A step by step guide to stopping antidepressants the right way, first time

Quitting Antidepressants the Smart Way - A step by step guide to stopping antidepressants the right way, first time


ALMOST 70% OFF FOR A LIMITED TIME ONLY! Normally $2.99Completely updated for 2014 with the latest advanced in our understanding of SSRI DiscontinuationEverything you need to know to ensure you have a "soft landing" as you come off antidepressantsA guide to getting off SSRI antidepressants and starting your drug free life again, from Benjamin Kramer, best-selling author of "Brain Renovation".In this clear and concise guide, Benjamin Kramer gives you an easy to implement blueprint for coming off antidepressants such as SSRIs (Selective Serotonin Re-uptake Inhibitors) using a variety of little-known techniques and tips.With a scientifically-designed tapering plan, including the use of certain other drugs and supplements where required, you can avoid coming in for landing too hard and...

Antidepressants: What Every Patients Needs to Know (The Educated Patient Series)

Antidepressants: What Every Patients Needs to Know (The Educated Patient Series)


Over 27 million Americans now take antidepressant medications.

According to the FDA, “No matter your age, before you take an antidepressant, you, your parent, or your caregiver should talk to your doctor about the risks and benefits of treating your condition with an antidepressant or with other treatments.”

When prescribing a new medication, two thirds of doctors do not talk to their patients about adverse side effects. Patients and caregivers deserve to have this information.

This book includes the side effects, overdose symptoms, withdrawal symptoms, important warnings and adverse reactions connected with antidepressant drugs.

Difficult to understand terms are simply defined in the over 500 word glossary.



© 2014 BrightSurf.com